Search

everythinglearnresearchcommunity

for

Search:↓

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

The cat improved with treatment but had kidney issues from long-term allopurinol use.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Targeting colon cancer stem cells might lead to better treatment results.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Addressing hair loss's psychological effects with mental health support is crucial for cancer survivors.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Bortezomib chemotherapy can cause temporary skin rashes.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Zinc levels remained low despite treatment, likely due to absorption issues.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Kerion cases had longer disease duration but responded well to antifungal treatments.